• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Jing, LIU Hongxia, CAI Dongcheng, HE Chaoyong. Advances in pancreatic β-cell protective strategies[J]. Journal of China Pharmaceutical University, 2020, 51(5): 622-627. DOI: 10.11665/j.issn.1000-5048.20200515
Citation: WANG Jing, LIU Hongxia, CAI Dongcheng, HE Chaoyong. Advances in pancreatic β-cell protective strategies[J]. Journal of China Pharmaceutical University, 2020, 51(5): 622-627. DOI: 10.11665/j.issn.1000-5048.20200515

Advances in pancreatic β-cell protective strategies

Funds: This study was supported by National Natural Science Foundation of China (No. 81670425); and the Specially-Appointed Professors Program of Jiangsu Province (No.1170010014)
More Information
  • Received Date: December 29, 2019
  • Revised Date: June 17, 2020
  • Pancreatic β cells, the only cells in the body that can synthesize and secrete insulin, can be damaged by a variety of pathological factors. Increasing attention has been paid to the studies of protecting pancreatic β cells in the treatment of diabetes. In this review, we highlight the studies that focus on enhancement of islet β cell function, reduction of islet β cell apoptosis, increase of islet β cell number and induction of islet β cell differentiation, providing novel targets and therapeutic strategies for the treatment of diabetes.
  • [1]
    . Nature,2019,576(7785):51?60.
    [2]
    Rines AK,Sharabi K,Tavares CD,et al. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes[J]. Nat Rev Drug Discov,2016,15(11):786?804.
    [3]
    Gray SM,Page LC,Tong J. Ghrelin regulation of glucose metabolism[J]. J Neuroendocrinol,2019,31(7):e12705. doi:10.1111/jne.12705.
    [4]
    Yang J,Wu L,Zhou LZ,et al. MiR-96 promotes insulin biosynthesis and secretion in mouse β cells through targeting Sox6[J]. J Pract Med(实用医学杂志),2019,35(2):196?200.
    [5]
    Villamayor L,Rodríguez-Seguel E,Araujo R,et al. GATA6 controls insulin biosynthesis and secretion in adult β-cells[J]. Diabetes,2018,67(3):448?460.
    [6]
    Dalmas E. Innate immune priming of insulin secretion[J]. Curr Opin Immunol,2019,56:44?49.
    [7]
    Xiao XW,Gaffar I,Guo P,et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7[J]. Proc Natl Acad Sci U S A,2014,111(13):E1211?E1220.
    [8]
    Criscimanna A,Coudriet GM,Gittes GK,et al. Activated macrophages create lineage-specific microenvironments for pancreatic acinar- and β-cell regeneration in mice[J]. Gastroenterology,2014,147(5):1106?1118.e11.
    [9]
    Dalmas E,Lehmann FM,Dror E,et al. Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production[J]. Immunity,2017,47(5):928?942.e7.
    [10]
    Zhang Q,Pan Y,Zeng BH,et al. Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells[J]. Cell Res,2019,29(7):516?532.
    [11]
    Jiang YL,Huang W,Wang J,et al. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy[J]. Int J Biol Sci,2014,10(3):268?277.
    [12]
    Drucker DJ,Nauck MA. The incretin system:glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes[J]. Lancet,2006,368(9548):1696?1705.
    [13]
    Yoon JW,Jun HS. Autoimmune destruction of pancreatic beta cells[J]. Am J Ther,2005,12(6):580?591.
    [14]
    Haythorne E,Rohm M,van de Bunt M,et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells[J]. Nat Commun,2019,10(1):2474.
    [15]
    Zhang EM,Mohammed Al-Amily I,Mohammed S,et al. Preserving insulin secretion in diabetes by inhibiting VDAC1 overexpression and surface translocation in β cells[J]. Cell Metab,2019,29(1):64?77.e6.
    [16]
    Cheng FR,Cui HX,Fang JL,et al. Ameliorative effect and mechanism of the purified anthraquinone-glycoside preparation from Rheum palmatum L. on type 2 diabetes mellitus[J]. Molecules,2019,24(8):E1454.
    [17]
    Brooks-Worrell BM,Palmer JP. Setting the stage for islet autoimmunity in type 2 diabetes:obesity-associated chronic systemic inflammation and endoplasmic reticulum (ER) stress[J]. Diabetes Care,2019,42(12):2338?2346.
    [18]
    McCullough KD,Martindale JL,Klotz LO,et al. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state[J]. Mol Cell Biol,2001,21(4):1249?1259.
    [19]
    Lipson KL,Fonseca SG,Ishigaki S,et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1[J]. Cell Metab,2006,4(3):245?254.
    [20]
    Odisho T,Zhang LL,Volchuk A. ATF6β regulates the Wfs1 gene and has a cell survival role in the ER stress response in pancreatic β-cells[J]. Exp Cell Res,2015,330(1):111?122.
    [21]
    Duan HL,Lee JW,Moon SW,et al. Discovery,synthesis,and evaluation of 2,4-diaminoquinazolines as a novel class of pancreatic β-cell-protective agents against endoplasmic reticulum (ER) stress[J]. J Med Chem,2016,59(17):7783?7800.
    [22]
    Duan HL,Li Y,Arora D,et al. Discovery of a benzamide derivative that protects pancreatic β-cells against endoplasmic reticulum stress[J]. J Med Chem,2017,60(14):6191?6204.
    [23]
    Meier JJ,Butler AE,Saisho Y,et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans[J]. Diabetes,2008,57(6):1584?1594.
    [24]
    Kumar A,Katz LS,Schulz AM,et al. Activation of Nrf2 is required for normal and ChREBPα-augmented glucose-stimulated β-cell proliferation[J]. Diabetes,2018,67(8):1561?1575.
    [25]
    El Ouaamari A,O-Sullivan I,Shirakawa J,et al. Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion[J]. J Biol Chem,2019,294(3):1059?1069.
    [26]
    Wang P,Alvarez-Perez JC,Felsenfeld DP,et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication[J]. Nat Med,2015,21(4):383?388.
    [27]
    Shen WJ,Taylor B,Jin QH,et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation[J]. Nat Commun,2015,6:8372.
    [28]
    Rachdi L,Kariyawasam D,Guez F,et al. Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass[J]. Diabetologia,2014,57(5):960?969.
    [29]
    Rutter GA,Pullen TJ,Hodson DJ,et al. Pancreatic β-cell identity,glucose sensing and the control of insulin secretion[J]. Biochem J,2015,466(2):203?218.
    [30]
    Pagliuca FW,Millman JR,Gürtler M,et al. Generation of functional human pancreatic β cells in vitro[J]. Cell,2014,159(2):428?439.
    [31]
    Veres A,Faust AL,Bushnell HL,et al. Charting cellular identity during human in vitro β-cell differentiation[J]. Nature,2019,569(7756):368?373.
    [32]
    Navarro-Tableros V,Gomez Y,Brizzi MF,et al. Generation of human stem cell-derived pancreatic organoids (POs) for regenerative medicine[J]. Adv Exp Med Biol,2020,1212:179?220.
    [33]
    Saxena P,Heng BC,Bai P,et al. A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells[J]. Nat Commun,2016,7:11247.
    [34]
    Sancho R,Gruber R,Gu GQ,et al. Loss of Fbw7 reprograms adult pancreatic ductal cells into α,δ,and β cells[J]. Cell Stem Cell,2014,15(2):139?153.
    [35]
    Lin HT,Kao CL,Lee KH,et al. Enhancement of insulin-producing cell differentiation from embryonic stem cells using pax4-nucleofection method[J]. World J Gastroenterol,2007,13(11):1672?1679.
    [36]
    Rovira M,Huang W,Yusuff S,et al. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation[J]. Proc Natl Acad Sci U S A,2011,108(48):19264?19269.
    [37]
    Cao LJ,Zhu KN,Jiang CH,et al. Intervention effects of the extract of Alismatis Rhizoma on streptozotocin-induced type 2 diabetic rats[J]. J China Pharm Univ(中国药科大学学报),2017,48(5):601?608.
    [38]
    Xu ZM,Zhu JJ,Jiang ZZ,et al. Hypoglycemic effects of terpenes from Fructus Corni on db / db diabetic mice[J]. J China Pharm Univ(中国药科大学学报),2016,47(3):337?341.
  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, ZHANG Hua, ZHANG Pingping, HU Guoqiang. Synthesis and antitumor activities of 1, 2-benzothiazines[1, 3, 4]thiadiazolo[3, 2-a][1, 3, 5]triazin derivatives[J]. Journal of China Pharmaceutical University, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
    [2]LI Jing, REN Yuejiao, GUAN Su, ZHANG Lei. Synthesis and xanthine oxidase inhibitory activities of 2-phenyl-tetrahydrothiopyrano[4, 3-d] pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(3): 294-300. DOI: 10.11665/j.issn.1000-5048.20150306
    [3]DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584.
    [4]DU Ping, ZHANG Di, ZHANG Guo-min, REN Shu-juan, GONG Guo-qing, XU Yun-gen. Synthesis and Na+/H+ exchanger 1 inhibitory activity of substituted benzoylguanidine-trimetazidine conjugates[J]. Journal of China Pharmaceutical University, 2011, 42(1): 22-28.
    [5]Synthesis and Biological Activity Study on N-( 3,4- Dimethoxyphenylethyl )-4-Subtituted Phenylpiperazine-1- Acetamide Series as α1-Adrenoceptor Antagonists[J]. Journal of China Pharmaceutical University, 2004, (1): 9-13.
    [6]Synthesis and Biologic Activities on 1-{1-[2-(3,4-Dimethoxy)Phenylethyl]-5-Cyano-6-Methyl-Uracil-3yl}-3-Substituted Amino-2-Propanol Compounds[J]. Journal of China Pharmaceutical University, 2003, (5): 10-13.
    [7]Synthesis andAntihypertensive Activity of 1-Phenylethyl(or 3,4-Dimethyloxyphenylethyl)-4-substitutedAryloxypiperidines[J]. Journal of China Pharmaceutical University, 2001, (3): 22-26.
    [8]Synthesis and Bioactivity of 1-Aryl-3-Alkyl-1, 4-Dihydro-4-Substituted-5H-1,2,4-triazolinones-5[J]. Journal of China Pharmaceutical University, 1999, (5): 323-327.
    [9]Synthesis and Inhibitor Activity to Phosphodiesterase of Thieno [3, 4-d] Pyrimidine-2,4-Dione Derivatives[J]. Journal of China Pharmaceutical University, 1991, (3): 142-144.
    [10]Synthesis of Thieno [3,4-d] Pyrimidine-2,4-Dione Derivatives[J]. Journal of China Pharmaceutical University, 1990, (4): 193-197.

Catalog

    Article views (317) PDF downloads (685) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return